These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 1386485)

  • 21. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
    Moore JP; McKeating JA; Weiss RA; Sattentau QJ
    Science; 1990 Nov; 250(4984):1139-42. PubMed ID: 2251501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multistep procedure for the chemical inactivation of human immunodeficiency virus for use as an experimental vaccine.
    Race E; Stein CA; Wigg MD; Baksh A; Addawe M; Frezza P; Oxford JS
    Vaccine; 1995 Nov; 13(16):1567-75. PubMed ID: 8578844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120.
    Leavitt M; Park EJ; Sidorov IA; Dimitrov DS; Quinnan GV
    J Virol; 2003 Jan; 77(1):560-70. PubMed ID: 12477860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor.
    Platt EJ; Madani N; Kozak SL; Kabat D
    J Virol; 1997 Feb; 71(2):883-90. PubMed ID: 8995604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermodynamic and kinetic analysis of sCD4 binding to HIV-1 virions and of gp120 dissociation.
    Moore JP; Klasse PJ
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):443-50. PubMed ID: 1599754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A global neutralization resistance phenotype of human immunodeficiency virus type 1 is determined by distinct mechanisms mediating enhanced infectivity and conformational change of the envelope complex.
    Park EJ; Gorny MK; Zolla-Pazner S; Quinnan GV
    J Virol; 2000 May; 74(9):4183-91. PubMed ID: 10756031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.
    McKenna PM; Pomerantz RJ; Dietzschold B; McGettigan JP; Schnell MJ
    J Virol; 2003 Dec; 77(23):12782-94. PubMed ID: 14610200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.
    Burrer R; Haessig-Einius S; Aubertin AM; Moog C
    J Virol; 2003 Nov; 77(21):11385-97. PubMed ID: 14557624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120.
    Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
    Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
    Virology; 1992 Mar; 187(1):233-41. PubMed ID: 1736526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120.
    McKeating JA; Cordell J; Dean CJ; Balfe P
    Virology; 1992 Dec; 191(2):732-42. PubMed ID: 1280382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.
    Barbas CF; Björling E; Chiodi F; Dunlop N; Cababa D; Jones TM; Zebedee SL; Persson MA; Nara PL; Norrby E
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9339-43. PubMed ID: 1384050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Permissivity of primary cultures of human Kupffer cells for HIV-1.
    Schmitt MP; Gendrault JL; Schweitzer C; Steffan AM; Beyer C; Royer C; Jaeck D; Pasquali JL; Kirn A; Aubertin AM
    AIDS Res Hum Retroviruses; 1990 Aug; 6(8):987-91. PubMed ID: 2121193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry.
    DeSantis MC; Kim JH; Song H; Klasse PJ; Cheng W
    J Biol Chem; 2016 Jun; 291(25):13088-97. PubMed ID: 27129237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4.
    Kost TA; Kessler JA; Patel IR; Gray JG; Overton LK; Carter SG
    J Virol; 1991 Jun; 65(6):3276-83. PubMed ID: 1709701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in the interaction of HIV-1 and HIV-2 with CD4.
    Looney DJ; Hayashi S; Nicklas M; Redfield RR; Broder S; Wong-Staal F; Mitsuya H
    J Acquir Immune Defic Syndr (1988); 1990; 3(7):649-57. PubMed ID: 1693676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV requires multiple gp120 molecules for CD4-mediated infection.
    Layne SP; Merges MJ; Dembo M; Spouge JL; Nara PL
    Nature; 1990 Jul; 346(6281):277-9. PubMed ID: 2374593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
    Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.